Hetero Labs Archives - Express Pharma

MSD signs voluntary licensing agreements with five Indian pharma firms for Molnupiravir

GSK Pharma board approves sale of Vemgal facility to Hetero Labs for Rs 180 crores

Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData

Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage

Cipla to price remdesivir version for COVID-19 under 5,000 rupees

Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir

Dr Reddy’s halts worldwide supply of ranitidine

3 Indian cos receive US FDA nod for 1st generic Abilify to treat mental illnesses